CONMED Corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. Our products are technological leaders in the specialties that we serve: Orthopaedics, General Surgery, Gynecology, Gastroenterology, Pulmonology, and Anesthesiology. CONMED's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. Our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. We strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. CONMED is headquartered in beautiful, upstate New York (Utica), and employs approximately 3500 people worldwide. Our employees are located in 8 manufacturing, distribution or design facilities in the United States and in sales offices throughout the world. Our domestic locations include: Utica, NY, Largo, FL, Anaheim CA, San Mateo, CA, Westborough, MA, Edison, NJ, Centennial, CO, and Atlanta, GA. Our international facilities and presence spans more than 20 locations throughout Europe, Australia, Latin America, Asia, North America and the Middle East.

Type
Public
HQ
Utica, US
Founded
1970
Employees
3,400 (est)
Conmed was founded in 1970 and is headquartered in Utica, US

Conmed Locations

Utica, US
Tallahassee, US
Wilmington, US
Tucson, US
Fresno, US
Washington, US
Oklahoma City, US
Denver, US
Baton Rouge, US
Boise, US
Salem, US
Cincinnati, US
Fayetteville, US
Greensboro, US
San Francisco, US
Raleigh, US
Milwaukee, US
Sacramento, US
Wichita, US
New York, US

Conmed Metrics

Conmed Summary

Market capitalization

$1.21 B

Closing share price

$43.6
Conmed's current market capitalization is $1.21 B.

Conmed Financials

Conmed's revenue is $719 M in FY, 2015 which is 2.82% decrease from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$763 M$740 M$719 M

Gross profit

$412 M$404 M$382 M

Operating income

$56.5 M$52.8 M$51.2 M

Operating expense total

$356 M$351 M$331 M

Net Income

$35.9 M$32.2 M$30.5 M

Operating cash flow

$30.7 M$11.9 M$6.17 M

    Conmed Market Value History

    Conmed Company Life

    You may also be interested in